Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Sheidaei

Showing results (111-120 of 111) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 111 results.
Vaccine: X|November 9, 2023
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trialAkram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, et al.
Pageof 12

Showing results (111-120 of 111) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 111 results.
Vaccine: X|November 9, 2023
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trialAkram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, et al.
Pageof 12